Login / Signup

Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.

David A AndraeRachael F GraceAdrian JewettBrandon FosterRobert J KlaassenSam SalekJunlong LiFeng TaiAudra N BoscoeErin Zagadailov
Published in: Journal of patient-reported outcomes (2023)
gov/ct2/show/NCT03548220 .
Keyphrases
  • protein kinase
  • tyrosine kinase
  • replacement therapy
  • computed tomography
  • study protocol
  • clinical trial
  • phase iii
  • phase ii
  • positron emission tomography
  • magnetic resonance
  • open label
  • smoking cessation